{"id":"W2054701585","doi":"10.3816/ccc.2007.n.017","title":"Phase II Trial of Oxaliplatin/Irinotecan/5-Fluorouracil/Leucovorin for Metastatic Colorectal Cancer","year":2007,"lang":"en","type":"article","venue":"Clinical Colorectal Cancer","topic":"Colorectal Cancer Treatments and Studies","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":false,"ca_institutions":"Saskatchewan Cancer Agency","funders":"National Cancer Institute; Mayo Clinic; U.S. Department of Health and Human Services","keywords":"Medicine; Irinotecan; Oxaliplatin; Internal medicine; Regimen; Colorectal cancer; Fluorouracil; Clinical endpoint; Phases of clinical research; Leukopenia; Gastroenterology; Oncology; Toxicity; Chemotherapy; Cancer; Clinical trial","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001640925,0.001781347,0.003094332,0.0006480538,0.0006213353,0.00107217,0.001034321,0.001515031,0.005419629],"category_scores_gemma":[0.0010221,0.0006677089,0.001473642,0.0006219845,0.001391634,0.0009825302,0.0004651477,0.003738069,0.0009572123],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00142414,"about_ca_system_score_gemma":0.002123042,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.003612628,"about_ca_topic_score_gemma":0.007812824,"domain_scores_codex":[0.9995394,0.0002216898,0.00001660677,0.00007394273,0.00002919764,0.0001193033],"domain_scores_gemma":[0.9992216,0.0001193479,0.000103753,0.00006144376,0.00003548828,0.0004583441],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.8843027,0.03295613,0.001891098,0.0007651501,0.001118527,0.0001916933,0.0001905692,0.002152027,0.01576895,0.0003590538,0.003790081,0.05651407],"study_design_scores_gemma":[0.7800872,0.2121327,0.003484257,0.00002792995,0.0003080168,0.0001373108,0.00005021895,0.0006908009,0.001448145,0.0001374441,0.001479967,0.00001615537],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9890847,0.002994066,0.0005424946,0.0009802718,0.0003567536,0.002057698,0.001066006,0.0001178645,0.00280017],"genre_scores_gemma":[0.9829623,0.002768033,0.001770605,0.001311593,0.000315828,0.00210241,0.002923451,0.00004666837,0.005799093],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.005419629,"threshold_uncertainty_score":0.01813048,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.108756247030221,"score_gpt":0.4676305975531156,"score_spread":0.3588743505228946,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}